IGNITE Q&A Webinar

Webinar 3:30 - 4:30 PM EDT
Phone Number: 1-650-479-3208
Access Code:       126 433 4305

The NINDS IGNITE (Innovation Grants to Nurture Initial Translational Efforts) program is a multi-component suite of funding opportunities that is meant to facilitate the discovery and development of early-stage therapeutic biotechnology products.  The following three funding opportunities have upcoming receipt dates of October 20, 2020 and February 17, 2021:

• PAR-18-761: Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
• PAR-18-762: Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)
• PAR-18-763: Development and Validation of Model Systems and/or Pharmacodynamic Markers to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)

The program serves as a feeder program to the later-stage therapy development programs launched by NINDS, namely the Cooperative Research to Enable and Advance Translational Enterprises (CREATE) for Biologics and Blueprint Neurotherapeutics (BPN) programs.  An interactive Q&A session will be held for interested applicants on Thursday, July 16, 2020 from 3:30 - 4:30 PM EDT.  All potential IGNITE applicants are encouraged to participate.  Investigators can find information about these funding opportunities at the NINDS IGNITE website.

You can also submit questions before the meeting to timothy.Lyden@nih.gov.  While you can listen to the meeting by phone, all questions will need to be submitted online>/b>.

REGISTER

Phone Number: 1-650-479-3208
Access Code:       126 433 4305